KalVista Pharmaceuticals Presents Data on Unmet Needs in HAE from a Patient Perspective at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting : vimarsana.com

– Patient perspectives revealed frequent treatment delays, suboptimal clinical outcomes and substantial anxiety associated with injectable on-demand treatments, including those who received...

Related Keywords

Campbelltown , New South Wales , Australia , New York , United States , Japan , Cleveland , Ohio , Toronto , Ontario , Canada , La Jolla , California , San Diego , University Of California San Diego , Howard University Hospital , District Of Columbia , Sydney , Washington , American , Constance Katelaris , Sandra Christiansen , Stephen Betschel , James Wedner , Bob Geng , Andrew Crockett , Paula Busse , American Academy Of Allergy , Washington University School Of Medicine , Division Of Clinical Immunology , Department Of Medicine , Division Of Allergy , Exchange Commission , Division Of Pediatric Allergy , Sydney University , University Hospitals Rainbow Babies , Nasdaq , University Of California , University Of Toronto , Kalvista Pharmaceuticals Inc , Kalvista Pharmaceuticals , Annual Meeting , Poster Presentation , On Demand Treatment , Hereditary Angioedema Attacks , Patient Perceptions , Associated Barriers , California San Diego , Hereditary Angioedema , Washington University School , Refilling On Demand Therapy , Treatment Delay , Autumn Burnette , Negative Impact , Delayed On Demand Treatment , Princess Ogbogu , Pediatric Allergy , Clinical Immunology , Mount Sinai , Patients With , Prophylactic Treatment , Patients Requiring Redosing , On Demand Treatment After , Campbelltown Hospital , Western Sydney University , Chief Executive Officer , Vista Pharmaceuticals , Securities Litigation Reform Act , Markets ,